Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.
(Image credit: Fred Tanneau)
Continue reading
NPR News supplies a brief version of this story through its feed. Continue to the original publication for the complete report.
Read the original at NPR NewsSources & methodology
Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'NPR News
Republican senator Lisa Murkowski of Alaska said she will oppose president Donald Trump’s nominee for attorney general Sign up for the Breaking News US email Progressive Democratic proposals including ‘Medicare for all’ and new taxes on billionaires have powered insurgent candidates to primary victories this year, shaking the party establishment and leading it to worry about how Democrats will perform in November’s midterm elections. But a Reuters/Ipsos poll concluded early this week found those ideas – though by no means all of the progressive agenda – are supported by independent voters who could be decisive in determining whether president Donald Trump’s Republican Party maintains its congressional majorities for the next two years. Continue reading...
Many people feel that antidepressants block their true emotions, but they don’t have guidance about how to get off these drugs.
Houthis' expansion of cross-border attacks means an even bloodier war may be imminent, analysts say